Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Ludwigshafen Am Rhein – page 6

99 clinical trials in Ludwigshafen Am Rhein, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Ludwigshafen Am Rhein at a glance
99
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

99 trials in Ludwigshafen Am Rhein

Open in trial search

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Ladarixin
  • Sponsor:Dompe' Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pegcetacoplan
  • Sponsor:Apellis Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Malignant melanoma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Ludwigshafen Am Rhein

What the registry says about research in the country

01 Ophthalmology Research

Groundbreaking trials focusing on age-related macular degeneration and retinal conditions, including studies of innovative treatments for geographic atrophy and wet AMD. Research encompasses new drug delivery systems and therapeutic approaches for retinal vein occlusion.

  • Macular Degeneration Therapies
  • Retinal Vascular Disorders
  • Vision Preservation Treatments
02 Gastroenterology Studies

Multiple investigations into inflammatory bowel diseases, with particular focus on Crohn's Disease and ulcerative colitis. Studies evaluate novel therapeutic combinations and long-term treatment efficacy.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatments
  • Innovative Drug Therapies
03 Oncology & Hematology

Advanced research in blood cancers and solid tumors, including studies on multiple myeloma, acute myeloid leukemia, and non-small cell lung cancer. Trials explore innovative combination therapies and maintenance treatments.

  • Blood Cancer Therapies
  • Lymphoma Treatments
  • Targeted Cancer Therapies
04 Cardiovascular Medicine

Critical studies addressing acute myocardial infarction and related conditions. Research focuses on emergency interventions and preventive treatments for patients at risk of recurrent heart attacks.

  • Heart Attack Prevention
  • Emergency Cardiac Care
  • Innovative Cardiac Therapies
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.